Wellington Partners

HepaRegeniX GmbH, founded in 2016 and based in Ulm, Germany, focuses on developing innovative drugs for acute and chronic liver diseases. The company's therapeutic approach is centered on a proprietary molecular target known as mitogen-activated protein kinase 4 (MKK4), identified as a crucial regulator of liver regeneration through research by Professor Lars Zender and his team at the University Hospital Tübingen. HepaRegeniX aims to create small-molecule inhibitors of MKK4 that can enhance the regenerative capacity of hepatocytes, even in severely diseased livers. This research has significant implications for treating various liver disorders, including nonalcoholic steatohepatitis.

Aignostics GmbH, founded in 2018 and based in Berlin, Germany, specializes in AI-powered diagnostics and pathology software solutions aimed at enhancing pharmaceutical research and clinical diagnostics. The company focuses on precision diagnostics in pathology, employing its patented technology to create explainable AI systems that address the limitations of traditional AI models. By generating precise heatmaps and image overlays, Aignostics' platform enables pathologists to quickly verify AI-generated diagnostic results. This capability is essential for ensuring accuracy in diagnoses, particularly for complex diseases such as cancer. The company's innovative approach supports the discovery and validation of biomarkers, facilitating improved diagnosis and treatment strategies in precision medicine.

Sphingotec GmbH, established in 2002 and based in Brandenburg, Germany, specializes in developing blood-based protein biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions. These conditions include acute heart failure, acute kidney injury, and circulatory shock. The company's portfolio also extends to developing monoclonal antibody therapies in combination with targeted diagnostic tests, aiming to improve the management and recovery of critically ill patients.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Nyra Health is a digital therapy platform founded in 2020 and headquartered in Vienna, Austria. It focuses on addressing personal neurological deficits through an artificial intelligence-driven application. The platform provides evidence-based therapies that can be utilized in clinics or at home, making rehabilitation accessible regardless of time or location. By leveraging advanced technology, Nyra Health aims to empower patients to maximize their rehabilitation potential effectively.

Orcan Energy AG, founded in 2008 and based in Munich, Germany, specializes in the development and sale of energy solutions that convert waste heat into electricity using Organic Rankine Cycle (ORC) technology. The company provides ORC modules designed for various sectors, including industrial, automotive, marine, and biogas markets. Their products, such as the PACK 20.30 and PACK 05.15, effectively transform waste heat from exhaust gases and cooling water into grid-compatible electricity, catering to both high and low temperature applications. Orcan Energy aims to capitalize on the significant energy potential of unused industrial waste heat sources, offering efficient and economical solutions that operate independently and safely, even under partial load conditions. The company has also received support from various German governmental initiatives and maintains a focus on innovative, compact, and cost-effective energy generation technologies. As of October 2020, Orcan Energy AG operates as a subsidiary of E.ON SE.

Aignostics GmbH, founded in 2018 and based in Berlin, Germany, specializes in AI-powered diagnostics and pathology software solutions aimed at enhancing pharmaceutical research and clinical diagnostics. The company focuses on precision diagnostics in pathology, employing its patented technology to create explainable AI systems that address the limitations of traditional AI models. By generating precise heatmaps and image overlays, Aignostics' platform enables pathologists to quickly verify AI-generated diagnostic results. This capability is essential for ensuring accuracy in diagnoses, particularly for complex diseases such as cancer. The company's innovative approach supports the discovery and validation of biomarkers, facilitating improved diagnosis and treatment strategies in precision medicine.

iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The firm focuses on creating innovative cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. By employing a systematic screening approach of human tumor cells, iOmx Therapeutics has identified several new targets and examined their mechanisms of action. The company's foundation is built upon the principles of cancer immune-checkpoint therapy, which aims to overcome the resistance mechanisms that tumors utilize to evade immune attacks. These resistance mechanisms often involve specific cell surface molecules that activate immune-inhibitory receptors on T cells. By neutralizing these negative interactions, iOmx Therapeutics seeks to reactivate the host immune response, ultimately enhancing the effectiveness of cancer treatments.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

Adrenomed AG is a clinical-stage biopharmaceutical company based in Hennigsdorf, Germany, focused on developing monoclonal antibody therapies for the treatment of sepsis and related conditions. The company's lead product candidate, Adrecizumab, is a humanized monoclonal antibody designed to target Adrenomedullin, a peptide hormone that plays a critical role in maintaining vascular integrity. Adrenomed aims to rescue vascular integrity in critically ill patients facing limited treatment options, particularly those suffering from septic shock and acute heart failure. The company employs a unique approach that combines its therapeutic antibody with a specific diagnostic tool that utilizes Adrenomedullin as a biomarker for patient identification. Adrenomed has established a strong intellectual property position, holding granted patents in all major markets for its innovative therapies.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.

AMBOSS GmbH is a digital platform based in Cologne, Germany, that caters to the needs of medical students and physicians. Founded in 2012, the company develops and markets a comprehensive medical study platform that offers valuable resources such as study materials and a question bank. The platform is designed to deliver medical knowledge quickly and efficiently, supporting users in their educational and professional endeavors. Originally established as MIAMED GmbH, AMBOSS has positioned itself as a physician-driven resource, enhancing the learning experience for those in the medical field.

Adrenomed AG is a clinical-stage biopharmaceutical company based in Hennigsdorf, Germany, focused on developing monoclonal antibody therapies for the treatment of sepsis and related conditions. The company's lead product candidate, Adrecizumab, is a humanized monoclonal antibody designed to target Adrenomedullin, a peptide hormone that plays a critical role in maintaining vascular integrity. Adrenomed aims to rescue vascular integrity in critically ill patients facing limited treatment options, particularly those suffering from septic shock and acute heart failure. The company employs a unique approach that combines its therapeutic antibody with a specific diagnostic tool that utilizes Adrenomedullin as a biomarker for patient identification. Adrenomed has established a strong intellectual property position, holding granted patents in all major markets for its innovative therapies.

Sphingotec GmbH, established in 2002 and based in Brandenburg, Germany, specializes in developing blood-based protein biomarkers for the diagnosis, prediction, and monitoring of acute medical conditions. These conditions include acute heart failure, acute kidney injury, and circulatory shock. The company's portfolio also extends to developing monoclonal antibody therapies in combination with targeted diagnostic tests, aiming to improve the management and recovery of critically ill patients.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.

Heliatek GmbH, based in Dresden, Germany, specializes in the development and production of organic solar films and photovoltaic cells. Its flagship product, HeliaSol, is an organic photovoltaics (OPV) solution that can be applied to various surfaces, making it suitable for building retrofitting, automotive applications, and other innovative projects. Heliatek caters to the building and construction material sector, as well as automotive manufacturers, offering tailored products like HeliaFilm for integration into façade and roofing systems. The company is recognized as a leader in organic photovoltaics, leveraging its ultra-light and flexible technology to provide sustainable energy solutions. Established in 2006, Heliatek has formed strategic partnerships with companies such as AGC Glass Europe and Reckli China, and it employs around 160 people across its facilities in Germany. The research and development of its technologies have received support from the Free State of Saxony, the Federal Republic of Germany, and the European Union.

Themis Bioscience N.V. is a clinical-stage biopharmaceutical company based in Vienna, Austria, specializing in immunomodulation to develop products aimed at protecting against infectious diseases. Founded in 2009, the company’s lead candidate, MV-CHIK, has successfully completed Phase II clinical trials for chikungunya treatment. Themis is also advancing vaccines targeting other infectious diseases, including Zika virus, Lassa fever, and MERS, along with developing therapeutics for cancer. Themis has established a research collaboration and exclusive licensing agreement with Merck & Co., enhancing its capabilities and market reach. The company is focused on progressing its innovative vaccine candidates through various clinical development phases while positioning itself as a valuable partner in the biotech and pharmaceutical sectors.

Heliatek GmbH, based in Dresden, Germany, specializes in the development and production of organic solar films and photovoltaic cells. Its flagship product, HeliaSol, is an organic photovoltaics (OPV) solution that can be applied to various surfaces, making it suitable for building retrofitting, automotive applications, and other innovative projects. Heliatek caters to the building and construction material sector, as well as automotive manufacturers, offering tailored products like HeliaFilm for integration into façade and roofing systems. The company is recognized as a leader in organic photovoltaics, leveraging its ultra-light and flexible technology to provide sustainable energy solutions. Established in 2006, Heliatek has formed strategic partnerships with companies such as AGC Glass Europe and Reckli China, and it employs around 160 people across its facilities in Germany. The research and development of its technologies have received support from the Free State of Saxony, the Federal Republic of Germany, and the European Union.

iOmx Therapeutics AG is a Munich-based company specializing in immuno-oncology target discovery and drug development. The firm focuses on creating innovative cancer therapeutics that target novel immune checkpoint modulators present on tumor cells. By employing a systematic screening approach of human tumor cells, iOmx Therapeutics has identified several new targets and examined their mechanisms of action. The company's foundation is built upon the principles of cancer immune-checkpoint therapy, which aims to overcome the resistance mechanisms that tumors utilize to evade immune attacks. These resistance mechanisms often involve specific cell surface molecules that activate immune-inhibitory receptors on T cells. By neutralizing these negative interactions, iOmx Therapeutics seeks to reactivate the host immune response, ultimately enhancing the effectiveness of cancer treatments.

Onward is developing an Implantable Neuro-stimulation System (INS) with real-time motion feedback and uses training tools to rehabilitate patients suffering from neurological disorders such as spinal cord injury (SCI).

AMBOSS GmbH is a digital platform based in Cologne, Germany, that caters to the needs of medical students and physicians. Founded in 2012, the company develops and markets a comprehensive medical study platform that offers valuable resources such as study materials and a question bank. The platform is designed to deliver medical knowledge quickly and efficiently, supporting users in their educational and professional endeavors. Originally established as MIAMED GmbH, AMBOSS has positioned itself as a physician-driven resource, enhancing the learning experience for those in the medical field.

4SC is a clinical-stage biopharmaceutical company focused on discovering and developing targeted, small-molecule drugs for the treatment of cancer and autoimmune diseases, particularly in areas with significant unmet medical needs. The company aims to offer innovative treatment options that enhance tolerability and efficacy, ultimately improving patients' quality of life. 4SC's drug development pipeline includes two clinical candidates, resminostat and Domatinostat, which are protected by a strong portfolio of patents. The company operates primarily in Germany and the European Union, while also generating revenue from various other countries.

ImevaX GmbH is a biopharmaceutical company based in Munich, Germany, established in 2014. The company specializes in developing targeted vaccines to address chronic and nosocomial infections, with a particular focus on immune evasion factors employed by various pathogens. Its lead candidate, IMX 101, is designed to combat Helicobacter pylori, a bacterium responsible for stomach ulcers and gastric cancer in humans. ImevaX's research highlights the role of specific bacterial factors that enable H. pylori to evade the host immune response, prompting further investigation into similar mechanisms in other infectious pathogens. The company's efforts aim to enhance treatment options and improve health outcomes for patients suffering from these persistent infections.

Heliatek GmbH, based in Dresden, Germany, specializes in the development and production of organic solar films and photovoltaic cells. Its flagship product, HeliaSol, is an organic photovoltaics (OPV) solution that can be applied to various surfaces, making it suitable for building retrofitting, automotive applications, and other innovative projects. Heliatek caters to the building and construction material sector, as well as automotive manufacturers, offering tailored products like HeliaFilm for integration into façade and roofing systems. The company is recognized as a leader in organic photovoltaics, leveraging its ultra-light and flexible technology to provide sustainable energy solutions. Established in 2006, Heliatek has formed strategic partnerships with companies such as AGC Glass Europe and Reckli China, and it employs around 160 people across its facilities in Germany. The research and development of its technologies have received support from the Free State of Saxony, the Federal Republic of Germany, and the European Union.

AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

Definiens is a company that specializes in image analysis and data mining solutions tailored for quantitative digital pathology within the life sciences, diagnostic biomarkers, and healthcare sectors. Its software offers detailed insights from whole tissue slides, cell-based assays, and full-body scans, enabling users to correlate this information with data from various sources. By automating analysis workflows, Definiens assists pharmaceutical and biotechnology firms, research institutions, clinical service organizations, and pathologists in generating new knowledge, thereby enhancing decision-making in research, diagnostics, and therapy. Headquartered in Munich, Germany, Definiens aims to advance research fields, contribute to the development of personalized medicine, and improve patient quality of life. The company also maintains offices across the United States.

Opvizor GmbH, founded in 2012 and based in Vienna, Austria, specializes in cloud-based expert systems designed to enhance the management of virtual IT infrastructures. Its flagship product, Opvizor, is an agent-less Software-as-a-Service application that offers automated detection of configuration and operational issues within VMware environments. By analyzing protocol files, configuration data, and performance metrics, Opvizor identifies potential system integrity and security vulnerabilities, allowing administrators to mitigate risks before they lead to costly downtime. The platform features a crowdsourced knowledge base, continuously updated with input from users, which enhances its predictive capabilities. Opvizor aims to optimize IT environments by providing comprehensive reports and efficient problem-solving guidance, ensuring greater stability and performance for data centers.

Dacuda is a computer vision company based in Zurich, Switzerland, with additional locations in Palo Alto, California, and Shanghai, China. The company specializes in developing software solutions that enhance camera capabilities through real-time 2D and 3D algorithms. Dacuda aims to simplify the process of 3D content creation for consumers, making it as straightforward as capturing a video. Its technology supports app-based scanning, facilitating the adoption of 3D applications in augmented and virtual reality. Additionally, Dacuda's offerings include low-cost solutions that enable high-quality scans, powerful text recognition, and the transformation of printed text and tables into editable formats. This technology streamlines data entry and content sharing for users. Dacuda has received several awards for its innovation and entrepreneurial achievements, highlighting its position as a leader in the software 3D camera market.

Orcan Energy AG, founded in 2008 and based in Munich, Germany, specializes in the development and sale of energy solutions that convert waste heat into electricity using Organic Rankine Cycle (ORC) technology. The company provides ORC modules designed for various sectors, including industrial, automotive, marine, and biogas markets. Their products, such as the PACK 20.30 and PACK 05.15, effectively transform waste heat from exhaust gases and cooling water into grid-compatible electricity, catering to both high and low temperature applications. Orcan Energy aims to capitalize on the significant energy potential of unused industrial waste heat sources, offering efficient and economical solutions that operate independently and safely, even under partial load conditions. The company has also received support from various German governmental initiatives and maintains a focus on innovative, compact, and cost-effective energy generation technologies. As of October 2020, Orcan Energy AG operates as a subsidiary of E.ON SE.

Sensimed AG is a medical devices company based in Lausanne, Switzerland, founded in 2003. The company specializes in the design, development, and commercialization of integrated micro-systems for medical applications, particularly focusing on glaucoma management. Its flagship product, the SENSIMED Triggerfish, is a soft, single-use contact lens that enables continuous monitoring of intraocular pressure (IOP) fluctuations in glaucoma patients over a 24-hour period. The Triggerfish system includes disposable sensors, an adhesive antenna for communication, a battery-powered recorder for data collection, and software for data management and analysis. Sensimed aims to enhance personalized treatment for glaucoma patients by analyzing the collected data to identify pathological patterns and improve clinical outcomes. The company's products are distributed through partners across Europe, Asia-Pacific, the Middle East, and the Americas. As of December 2019, Sensimed operates as a subsidiary of SEED Co., Ltd.

AYOXXA Biosystems GmbH is a life science tools company based in Cologne, Germany, with additional offices in Singapore and Boston, Massachusetts. Founded in 2010, AYOXXA specializes in developing a proprietary technology platform for multiplexed protein analysis. This platform, which utilizes In-situ Encoded Bead-based Arrays, enables users to simultaneously measure multiple protein markers associated with various health conditions, including cancer, allergies, cardiovascular diseases, and infectious diseases. AYOXXA's innovative biochips merge biological analysis with information technology, expanding the potential applications in biomedical research. The company also offers biomarker kits to facilitate the identification and quantification of proteins and other biomolecular analytes.

Readmill is a Berlin-based social reading platform that offers users the ability to read ebooks, highlight passages, and share these highlights with friends, fostering discussions around the content. Founded and led by CEO Henrik Berggren, Readmill has formed partnerships with several independent bookstores, including Leanpub, Readlists, Free-ebooks.net, Jottify, OR Books, Publit, and Bibliocrunch, enhancing its offerings and reach within the literary community. The platform aims to create a collaborative reading experience that combines individual engagement with social interaction.

bonusbox GmbH, founded in 2011 and based in Berlin, Germany, specializes in online loyalty programs and operates a multi-partner loyalty network. The company provides a customer retention platform that assists merchants in acquiring new customers and retaining existing ones through an incentive scheme. This approach aims to enhance customers' basket values and increase purchase frequencies. The platform is designed to integrate seamlessly into merchants' websites, allowing customers to earn points with each purchase. These points can be redeemed for rewards on the bonusbox platform, where users can also monitor their online purchases and accrued points while discovering additional partner shops. By structuring various customer data, bonusbox enables merchants to gain deeper insights into their customers' behaviors and preferences.

eWise is an international provider of personal financial management and account aggregation solutions, founded in 2000 and headquartered in Switzerland. The company offers a software platform that allows users to unify their financial accounts on a single screen, enhancing online payment, security, authentication, and wealth management. eWise Money Manager is utilized by several prominent banks, including HSBC, Westpac, and First Direct, demonstrating its credibility and innovative approach in the financial services sector. With operations spanning Europe, Asia, America, and Australia, eWise aims to facilitate a seamless and secure financial management experience for its users.

Sapiens Steering Brain Stimulation GmbH is a medical device company focused on advancing deep brain stimulation (DBS) therapy. Founded in 2011 as a spin-out of Royal Philips Electronics, the company aims to enhance patient comfort and therapeutic outcomes with its innovative, high-resolution, and MRI-compatible DBS system. Sapiens specializes in developing a comprehensive DBS solution that includes navigation and steering software, as well as implants specifically designed for patients with Parkinson's disease. With offices in Eindhoven, the Netherlands, and Munich, Germany, Sapiens leverages patented technologies to deliver effective and precise treatment options for individuals suffering from this neurological condition.

Enecsys Limited specializes in the development, manufacturing, and marketing of advanced solar micro inverters and monitoring systems designed for grid-connected solar photovoltaic (PV) applications. The company's micro inverters convert direct current (DC) power generated by individual solar modules into alternating current (AC) power for integration into the electricity grid. Key benefits of Enecsys micro inverters include maximized energy harvest, improved safety, enhanced reliability, and simplified design and installation processes. The accompanying monitoring system provides real-time performance tracking of each PV module, utilizing a robust wireless communication system that connects to the Internet. Enecsys is headquartered in Cambridge, UK, with additional sales and support offices in Germany, the USA, and Taiwan.

Orcan Energy AG, founded in 2008 and based in Munich, Germany, specializes in the development and sale of energy solutions that convert waste heat into electricity using Organic Rankine Cycle (ORC) technology. The company provides ORC modules designed for various sectors, including industrial, automotive, marine, and biogas markets. Their products, such as the PACK 20.30 and PACK 05.15, effectively transform waste heat from exhaust gases and cooling water into grid-compatible electricity, catering to both high and low temperature applications. Orcan Energy aims to capitalize on the significant energy potential of unused industrial waste heat sources, offering efficient and economical solutions that operate independently and safely, even under partial load conditions. The company has also received support from various German governmental initiatives and maintains a focus on innovative, compact, and cost-effective energy generation technologies. As of October 2020, Orcan Energy AG operates as a subsidiary of E.ON SE.

Experteer is an online career and recruitment marketplace based in Munich, Germany, specializing in high-end job opportunities across Europe. It features over 80,000 job listings targeted at senior-level professionals and offers access to a confidential network of more than 8,000 recruiters and 10,000 selected headhunters. The platform is designed to assist experienced executives in navigating their career moves and monitoring their market value, providing tailored insights and resources. With a dedicated team of recruitment professionals, Experteer conducts market research to classify job opportunities and apply salary benchmarks, ensuring quality listings for its users. Additionally, it serves recruitment needs through job advertising and candidate sourcing for headhunters and agencies. Founded in 2005, Experteer has established itself as a trusted resource in the high-end recruitment sector.

AZZURRO Semiconductors AG, based in Magdeburg, Germany, specializes in the manufacturing and marketing of gallium nitride on silicon (GaN-on-Si) epitaxial wafers. Founded in 2003, the company provides products that support the development of light-emitting diodes (LEDs) and various semiconductor applications. Its GaN-on-Si products are utilized in high voltage electronics, field-effect transistors (FETs), automotive components, power supply switching devices, sensors, and more. As of April 30, 2014, AZZURRO Semiconductors AG is under liquidation.

mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

Experteer is an online career and recruitment marketplace based in Munich, Germany, specializing in high-end job opportunities across Europe. It features over 80,000 job listings targeted at senior-level professionals and offers access to a confidential network of more than 8,000 recruiters and 10,000 selected headhunters. The platform is designed to assist experienced executives in navigating their career moves and monitoring their market value, providing tailored insights and resources. With a dedicated team of recruitment professionals, Experteer conducts market research to classify job opportunities and apply salary benchmarks, ensuring quality listings for its users. Additionally, it serves recruitment needs through job advertising and candidate sourcing for headhunters and agencies. Founded in 2005, Experteer has established itself as a trusted resource in the high-end recruitment sector.

eCircle is a provider of software and services for email marketing and digital dialog marketing in Europe. Founded in 1999 and headquartered in Munich, Germany, the company has expanded its presence with offices in the United Kingdom, France, Spain, the Netherlands, and Italy. eCircle offers software solutions for email and SMS broadcasting, along with email address data for newsletter mailings and various campaign types including email, SMS, and MMS. In addition to these services, the company provides consulting services and social media functionalities to enhance its marketing offerings.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

Evolva is a biotechnology company based in Reinach, Switzerland, that specializes in the development and commercialization of nature-based ingredients and innovative small-molecule compounds. Founded in 2004, Evolva leverages a proprietary synthetic biology platform to create high-quality ingredients that serve various applications, including flavors, fragrances, health ingredients, and health protection. By mimicking the chemical structures found in natural products, Evolva's technology offers solutions that avoid the limitations associated with traditional methods, thus providing a versatile approach to ingredient formulation and product development.

Heliatek GmbH, based in Dresden, Germany, specializes in the development and production of organic solar films and photovoltaic cells. Its flagship product, HeliaSol, is an organic photovoltaics (OPV) solution that can be applied to various surfaces, making it suitable for building retrofitting, automotive applications, and other innovative projects. Heliatek caters to the building and construction material sector, as well as automotive manufacturers, offering tailored products like HeliaFilm for integration into façade and roofing systems. The company is recognized as a leader in organic photovoltaics, leveraging its ultra-light and flexible technology to provide sustainable energy solutions. Established in 2006, Heliatek has formed strategic partnerships with companies such as AGC Glass Europe and Reckli China, and it employs around 160 people across its facilities in Germany. The research and development of its technologies have received support from the Free State of Saxony, the Federal Republic of Germany, and the European Union.

Evolva is a biotechnology company based in Reinach, Switzerland, that specializes in the development and commercialization of nature-based ingredients and innovative small-molecule compounds. Founded in 2004, Evolva leverages a proprietary synthetic biology platform to create high-quality ingredients that serve various applications, including flavors, fragrances, health ingredients, and health protection. By mimicking the chemical structures found in natural products, Evolva's technology offers solutions that avoid the limitations associated with traditional methods, thus providing a versatile approach to ingredient formulation and product development.

Symetis is a Swiss company based in Ecublens that specializes in developing innovative minimally invasive heart valve replacement therapies. The company focuses on improving patient care and safety through its proprietary Acurate™ Aortic Valve Replacement System, which features a unique self-positioning design. This design allows for easier implant positioning and alignment, enhancing the overall user experience for healthcare providers. Symetis aims to address the needs of patients suffering from aortic valve stenosis, enabling the effective treatment of severe cardiac valve conditions through its advanced transcatheter aortic valve implantation devices.

Enecsys Limited specializes in the development, manufacturing, and marketing of advanced solar micro inverters and monitoring systems designed for grid-connected solar photovoltaic (PV) applications. The company's micro inverters convert direct current (DC) power generated by individual solar modules into alternating current (AC) power for integration into the electricity grid. Key benefits of Enecsys micro inverters include maximized energy harvest, improved safety, enhanced reliability, and simplified design and installation processes. The accompanying monitoring system provides real-time performance tracking of each PV module, utilizing a robust wireless communication system that connects to the Internet. Enecsys is headquartered in Cambridge, UK, with additional sales and support offices in Germany, the USA, and Taiwan.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

GameDuell is a Berlin-based company that operates as a cross-platform games community, providing a diverse array of casual and social online games. Founded in 2003, it has amassed over 125 million registered players across its website, social networks, and mobile devices. The company boasts a portfolio of more than 70 games, including popular titles such as Fluffy, Maya Pyramid, and classic games like Hearts and Solitaire, with most of these games developed in-house. GameDuell is dedicated to offering free-to-play digital card and board games, action arcade games, and puzzle games, allowing users to engage with real players and win tangible prizes. With a team of 210 experienced professionals, GameDuell is recognized as a prominent provider of casual and social gaming experiences in Western markets.

Sensimed AG is a medical devices company based in Lausanne, Switzerland, founded in 2003. The company specializes in the design, development, and commercialization of integrated micro-systems for medical applications, particularly focusing on glaucoma management. Its flagship product, the SENSIMED Triggerfish, is a soft, single-use contact lens that enables continuous monitoring of intraocular pressure (IOP) fluctuations in glaucoma patients over a 24-hour period. The Triggerfish system includes disposable sensors, an adhesive antenna for communication, a battery-powered recorder for data collection, and software for data management and analysis. Sensimed aims to enhance personalized treatment for glaucoma patients by analyzing the collected data to identify pathological patterns and improve clinical outcomes. The company's products are distributed through partners across Europe, Asia-Pacific, the Middle East, and the Americas. As of December 2019, Sensimed operates as a subsidiary of SEED Co., Ltd.

Innovative Silicon was founded to develop and commercialise Floating Body effect memory for SoC/MPU products used in diverse applications including handheld computers, games consoles, cellular communications devices, cameras. The company closed its first round of VC funding in 2003, completed its first 90nm megabit Z-RAM memory design in 2004 and its first 65nm designs in 2005. The company was founded in 2002 and is headquartered in Santa Clara, California with additional offices in Lausanne, Switzerland; and Yokohama, Japan.

Experteer is an online career and recruitment marketplace based in Munich, Germany, specializing in high-end job opportunities across Europe. It features over 80,000 job listings targeted at senior-level professionals and offers access to a confidential network of more than 8,000 recruiters and 10,000 selected headhunters. The platform is designed to assist experienced executives in navigating their career moves and monitoring their market value, providing tailored insights and resources. With a dedicated team of recruitment professionals, Experteer conducts market research to classify job opportunities and apply salary benchmarks, ensuring quality listings for its users. Additionally, it serves recruitment needs through job advertising and candidate sourcing for headhunters and agencies. Founded in 2005, Experteer has established itself as a trusted resource in the high-end recruitment sector.

Heliatek GmbH, based in Dresden, Germany, specializes in the development and production of organic solar films and photovoltaic cells. Its flagship product, HeliaSol, is an organic photovoltaics (OPV) solution that can be applied to various surfaces, making it suitable for building retrofitting, automotive applications, and other innovative projects. Heliatek caters to the building and construction material sector, as well as automotive manufacturers, offering tailored products like HeliaFilm for integration into façade and roofing systems. The company is recognized as a leader in organic photovoltaics, leveraging its ultra-light and flexible technology to provide sustainable energy solutions. Established in 2006, Heliatek has formed strategic partnerships with companies such as AGC Glass Europe and Reckli China, and it employs around 160 people across its facilities in Germany. The research and development of its technologies have received support from the Free State of Saxony, the Federal Republic of Germany, and the European Union.

Adviqo Group, established in 2000 and based in Berlin, Germany, is a leading media organization specializing in live counseling services tailored for female audiences. It operates a diverse portfolio that includes TV channels, online marketplaces, eCommerce sites, websites, and mobile applications, focusing on life advice, therapeutic counseling, and coaching. The company has a significant presence across five countries—Germany, the UK, France, Spain, and Poland—employing over 350 staff members. Adviqo is recognized as an exclusive content partner for prominent women's magazines and major online platforms, enhancing its reach and influence. With a strong management team drawn from various reputable firms and supported by notable investors, Adviqo has consistently achieved high double-digit revenues and maintained profitability.

Ingent Inc., a Germany-based provider of information retrieval infrastructure technologies for computer applications.

mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

XING Is the social network for business professionals. More than 13 million members worldwide – over 6.5 million of whom are based in german-speaking countries – use xing to boost their business, job, and career. Xing is a platform where professionals from all kinds of different industries can meet up, find jobs, colleagues, new assignments, cooperation partners, experts and generate business ideas. Members can meet and exchange views in over 50,000 specialist groups, while also getting together at networking events. The platform is operated by xing ag, which was founded in hamburg, germany, in 2003, has been publicly listed since 2006, and listed on the tecdax since september 2011. In december 2010, xing acquired amiando ag, a munich-based company and europe’s leading provider of online event management and ticketing. The acquisition of kununu gmbh, the leading platform for employer reviews in german-speaking countries, allows xing to extend its position as the social recruiting market leader.

VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

Collax GmbH specializes in developing Linux-based server solutions tailored for small to medium-sized businesses. Founded in 2005 and headquartered in Ismaning, Germany, with additional offices in Munich and Boston, the company provides a range of products. Its offerings include the Collax Business Server, which facilitates network creation and maintenance, and the Collax OX Server, designed for efficient information exchange. The Collax Security Gateway serves as a unified threat management solution, enhancing network security. Additionally, Collax provides various integrated services, including data management, email, collaboration tools, and security features such as firewalls and virus protection. By focusing on adaptability, stability, and security, Collax aims to support its clients in improving productivity while ensuring robust IT infrastructure.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

VoiceObjects AG operates as a phone application server company. Its products include VoiceObjects Server, a phone application server that enables carrier-grade deployment and management of over-the-phone voice, video, text, and mobile Web self-service applications; and VoiceObjects Desktop, a GUI-based application for creating, testing, deploying, and monitoring self-service phone portals. The company also offers professional services, including consulting, training, and technical support services. Its customers include banking and financial services, communication, marketing agencies, industrial, travel and support, healthcare, government, entertainment and info-portals, and management service providers in the United States and internationally. The company has strategic partnerships with Alcatel, aperto move, Avaya, BEA, BusinessObjects, Cirquent GmbH, D+S solutions, EXCELSIS, Hermes SoftLab, Hewlett Packard, NextiraOne, Quinary, Sabio, Telenet GmbH, Unisys, and Voxeo. The company was formerly known as OneBridge AG and changed its name to VoiceObjects AG in July 2002. The company was founded in 2001 and is based in Bergisch Gladbach, Germany. As of December 9, 2008, VoiceObjects AG operates as a subsidiary of Voxeo Corporation.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

mtm laboratories AG is an ISO 9001 and 13485 certified developer and manufacturer of In-Vitro Diagnostics for the early detection and diagnosis of cervical and other cancers. With headquarters in Heidelberg, Germany, and subsidiaries in the United States, France, Italy and Spain, mtm markets its proprietary CINtec(R) Histology Kit and CINtec(R) Cytology Kit as adjunct tools for the early detection and diagnosis of cervical cancer. These kits are based on mtm's proprietary E6H4(TM) antibody clone which was specifically developed for immunochemistry applications in both formalin-fixed paraffin-embedded tissue sections and alcohol fixed cervical cytology preparations. The target for mtm's cervical cancer early detection technology platforms is the evaluation of the over-expression of the cyclin-dependent kinase inhibitor p16INK4a. This sensitive and selective antibody clone is combined with GMP manufactured kit components to ensure reproducible quality and results.

WLAN AG is a wireless local area network distributor. It focuses on the professional client support with regard to evaluation, planning, implementation, operation, and support of WLAN and network access control solutions. It offers its users with network engineering, operations, troubleshooting, and WLAN engineering services. The company offers solutions for network access controlling, public transport systems, and public WLAN. WLAN AG is a Switzerland-based company that was founded in 2004. The company was acquired by Swisscom Eurospot on March 7, 2003.

EnOcean GmbH, founded in 2001 and headquartered in Oberhaching, Germany, specializes in energy harvesting technology and wireless sensor solutions for building automation, industrial applications, and environmental monitoring. The company offers a range of products, including energy converters, wireless sensors, controllers, transmitters, receivers, and development tools, designed to enable maintenance-free, battery-less operations in various environments. EnOcean's innovative technology allows sensors to harvest energy from their surroundings, making them ideal for applications in smart homes, lighting systems, and automated meter reading. The company distributes its products through a network of partners across numerous countries, including Austria, Belgium, Canada, China, Germany, the United States, and several others in Europe and beyond. EnOcean's solutions aim to enhance energy efficiency and user convenience in the growing Internet of Things market.

eCircle is a provider of software and services for email marketing and digital dialog marketing in Europe. Founded in 1999 and headquartered in Munich, Germany, the company has expanded its presence with offices in the United Kingdom, France, Spain, the Netherlands, and Italy. eCircle offers software solutions for email and SMS broadcasting, along with email address data for newsletter mailings and various campaign types including email, SMS, and MMS. In addition to these services, the company provides consulting services and social media functionalities to enhance its marketing offerings.